The Affordable Care Act is not quite ready, some of the key aspects won't be available and many large corporations are still exempt, but it is rolling out for individuals tomorrow. 76% of U.S. adults are aware of the law's individual mandate - they know the law will require them to have insurance or pay penalties - but only 40% are aware that new health insurance marketplaces are (in many cases) opening on October 1, or that financial assistance that is available to help people with low or moderate incomes pay their health insurance premiums.

Oxytocin, colloquially called the 'love hormone' because of its correlation to mother-infant attachment and romantic bonding in adults, could also make us more accepting of other people, according to a new psychology paper. 

Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease. Some of the resources currently being devoted to breast and prostate screening programmes, where the evidence of effectiveness is much less clear-cut, should be reallocated to the early detection of CRC, the 2013 European Cancer Congress (ECC2013) [1] will hear today (Sunday).

The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress (ECC2013) [1].

 An old star, IRAS 15445-5449, is "blooming" in the southern sky — it has begun to push out a jet of charged particles that glow with radio waves. And astronomers are on the hunt to determine why 

Researchers recently used a laser to accelerate electrons at a rate 10 times higher than conventional technology in a nanostructured glass chip smaller than a grain of rice, an advance that could dramatically shrink particle accelerators for science and medicine.

 Because it employs commercial lasers and low-cost, mass-production techniques, the researchers believe it will set the stage for new generations of "tabletop" accelerators.

At its full potential, the new "accelerator on a chip" could match the accelerating power of SLAC's 2-mile-long linear accelerator in just 100 feet, and deliver a million more electron pulses per second.